Outcome of Patients With an Ultralow-Risk 70-Gene Signature in the MINDACT Trial. Lopes Cardozo JMN, Drukker CA, Rutgers EJT, Schmidt MK, et al. J Clin Oncol 2022;40:1335-1345.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lopes Cardozo JMN, Drukker CA, Rutgers EJT, Schmidt MK, et al. Outcome of Patients With an Ultralow-Risk 70-Gene Signature in the MINDACT Trial. J Clin Oncol 2022;40:1335-1345.
PMID: 35061525